Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaMark A. Dawson, Tony Kouzarides, Rab K. Prinjha et al.|Nature|2011Cited by 1.5k
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosisSergio E. Baranzini, Jorge R. Oksenberg, Joanne Wang et al.|Human Molecular Genetics|2008Cited by 479
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B. Pappalardi, Rab K. Prinjha, P Chapman et al.|Nature Cancer|2021Cited by 279
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein HomeostasisMikhail M. Savitski, Marcus Bantscheff, Nico Zinn et al.|Cell|2018Cited by 226
Inhibition of BET Recruitment to Chromatin As An Effective Treatment for MLL-Fusion LeukaemiaMark A. Dawson, Brian J.P. Huntly, Rab K. Prinjha et al.|Blood|2011Cited by 38